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ABSTRACT  The interactions of human genotype AO erythrocytes (red blood cells) (RBCs) with 
N-acetylgalactosamine-reactive  lectins  isolated  from  Helix pomatia (HPA)and  from  Dolichos 
biflorus (DBA) were studied.  Binding curves  obtained  with the use of tritium-labeled  lectins 
showed that the maximal numbers of lectin molecules capable of binding to human genotype 
AO RBCs were 3.8 x  105 and 2.7 x  105 molecules/RBC  for HPA and  DBA, respectively. The 
binding of one type of lectin  may influence the binding of another type.  HPA was found to 
inhibit the binding of DBA, but not vice versa. The binding of HPA was weakly inhibited  by a 
/~-D-galactose-reactive  lectin  isolated  from  Ricinus  communis  (designated  RCA1). Limufus 
polyphemus lectin  (LPA), with specificity  for N-acetylneuraminic  acid,  did  not influence  the 
binding of HPA but enhanced the binding of DBA. About 80% of LPA receptors (N-acetylneu- 
raminic acid)  were removed  from  RBC surfaces  by neuraminidase treatment.  Neuraminidase 
treatment of RBCs resulted in increases of binding of both HPA and DBA, but through different 
mechanisms.  An  equal  number (7.6 x  105) of new HPA sites were generated on genotypes 
AO  and  GO  RBCs by  neuraminidase  treatment,  and  these  new  sites  accounted  for  the 
enhancement (AO cells) and appearance (OO cells) of hemagglutinability by HPA. Neuramin- 
idase treatment did not generate new DBA sites, but increased  the DBA affinity for the existing 
receptors;  as a result,  genotype  AO  cells  increased  their  hemagglutinability  by  DBA, while 
GO cells  remained  unagglutinable.  The use of RBCs of different genotypes in binding assays 
with 3H-labeled  lectins  of known specificities  provides an  experimental  system  for studying 
cell-cell  recognition and association. 
Cell-cell  interaction  in  multicellular  organisms  is a  funda- 
mental  phenomenon  which  includes  cell-cell  recognition, 
communication,  adhesion,  and  rearrangement,  etc. Most of 
these interactions are mediated by the cell surface (1-3), which 
contains a number of surface membrane proteins or glycopro- 
teins  responsible for cellular recognition  or junction  forma- 
tion (4, 5). The cell surface membrane-bound glycosyltrans- 
ferases and the sugar acceptors have been implicated in dy- 
namic intercellular adhesion  and dissociation (6-8).  Lectins 
are a group of carbohydrate-binding proteins or glycoproteins 
isolated from plants and animals capable of recognizing spe- 
cific sugar residues and their linkages. Different types oflectins 
have  been  used  extensively  to  study  the  topology  of cell 
surfaces (2, 9), including cells during differentiation (10,  11) 
and after transformation (12). 
Many  lectins  can  agglutinate  human  erythrocytes  (red 
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blood  cells)  (RBCs) 1 (2).  Indeed,  RBC  agglutination  is  the 
usual method for detecting the presence oflectins in a solution 
and has contributed to the discovery of many lectins (13). A 
considerable number of lectins are blood group-specific, and 
some recognize A, B, H, Le  b, and N determinants (9,  14). In 
the present investigation, two blood group A-specific lectins, 
obtained from Helix pomatia (15-18) and Dolichos biflorus 
(19-21), were used to react with genotype AO human RBCs, 
with the aim of studying the interaction  of these molecules 
Abbreviations used in this paper-  DBA, Dolichos biflorus agglutinin 
or lectin; GalNAc, N-acetylgalactosamine;  HPA, Helb: pomatia ag- 
glutinin  or lectin;  LPA,  Limulus polyphemus agglutinin  or lectin; 
RBC, erythrocyte  of human, genotype AO, unless stated  otherwise; 
RCA1,  an agglutinin  isolated  from Ricinus communis;  TSA,  Tris- 
buffered saline containing  2.5 mg/ml of bovine serum albumin, pH 
7.4. 
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dating this specific recognition process of cell-cell association 
and dissociation. 
Helix  pomatia  lectin  (HPA,  A  standing  for  agglutinin), 
which  was  isolated  from  the  albumin  glands  of the  edible 
garden  snail (Helix pomatia),  consists of six  subunits,  each 
containing one carbohydrate binding site (15-17).  Dolichos 
biflorus lectin (DBA), which was extracted from the seeds of 
horse gram (Dolichos biflorus) (18), consists of four subunits, 
two  type  I  and  two  type  II;  only the type  I  subunits  bind 
carbohydrates (22). Both HPA and DBA resemble the anti-A 
antibodies in that they agglutinate human group A but not B 
or O  RBCs,  and  that  they  precipitate  with  blood  group  A 
substance and group C streptococcal polysaccharides ( 16,  19). 
DBA is even more restricted in its affinity toward blood group 
substances;  it  can  distinguish  subgroup  A~  from  other 
subgroups (23).  Both lectins were found to have combining 
sites specific for terminal nonreducing a-linked N-acetylgalac- 
tosamine  (GalNAc)  (16,  19,  24).  These  two  lectins  have 
overlapping but not identical specificities (25, 26), with HPA 
lectin having a broader sugar range than DBA. 
In  the  present  study,  HPA  and  DBA  labeled  with  [3H] 
acetic  anhydride  were  used  to  determine  the  equilibrium 
binding of HPA and DBA and the number of their receptor 
sites  on  the  genotype  AO  RBC  surface.  Experiments  were 
designed to evaluate and analyze the factors that may influ- 
ence the interactions of lectins with their receptors on RBCs, 
including the competition between lectins for common recep- 
tor  sites,  the  possible  roles  of steric  hindrance  and  charge 
interference by  other lectin  molecules, and the effect  of re- 
moval  of N-acetylneuraminic  acids.  The  analysis  of these 
experimental data has provided a molecular basis for under- 
standing  the  mechanism  of  hemagglutination  induced  by 
these lectins under different conditions. 
MATERIALS  AND  METHODS 
Materials:  [3H]  acetic  anhydride  (5.4  Ci/mM)  was  purchased  from 
Amersham Corp. (Arlington Heights, IL). DBA (molecular weight = 110,000), 
Limulus polyphemus lectin (LPA) (=400,000), HPA (=79,000), and an agglu- 
tinin isolated from Ricinus communis (RCA 1) (= 120,000) were purchased from 
E.Y.  Laboratory (San  Mateo,  CA).  HPA  was also purified in  E.A.  Kabat's 
Laboratory, with polyleucyl hog A  +  H  blood group substances as previously 
described (15).  The  purity of these lectin preparations is shown in  the SDS 
PAGE pattern (Fig.  1). PAGE was run according to the method of Fairbank et 
al. (27). 
Preparation of Tritiated Lectins:  A break-seal ampoule containing 
25  mCi of [~H] acetic anhydride, kept in dry ice with ethanol, was broken at 
the  fine  tip  by  two  4-5-mm  diameter glass beads  while the  ampoule  was 
stoppered with a  ground glass cone.  The  released [3H]  acetic anhydride was 
allowed to equilibrate with the previously added 1.25  ml of acetonitrile for  15 
min. A 50-ul volume of the equilibrated solution was pipetted into a glass test 
tube that contained  1 ml ofa  lectin solution (1  mg/ml) and 0.1  ml of  1 M 
carbonate buffer (pH 8.03), giving a [3H]acetic anhydride:lectin ratio of I mCi/ 
mg. Acetylation of HPA, DBA, and LPA was allowed to proceed at 4"C for 20 
h in the sealed test tubes. The radiolabeled lectin solutions were dialyzed against 
a large volume of 0.001  M phosphate buffered saline (PBS), pH 7.2, which was 
changed every 24 h for 8 d to remove free radioactivity. 
The  Residual Dialyzable  Radioactivity  of  Lectin Solu- 
tions:  Each radiolabeled lectin solution prepared as above (l or 2 ml) was 
dialyzed in a  small dialysis bag against an equal volume of PBS in a  tightly 
sealed small vial at 4"C with constant rotation for 8  d  without changing the 
external buffer solution. Every 24 h,  10 ul of solution outside of the dialysis 
bag  was  removed,  mixed with  3  ml  of Soluene  350  and  6  ml  of  toluene 
(containing Ominflour, 4.0 g/liter), and counted in a liquid scintillation  counter 
(Siemens Gammasonics Inc.,  Des  Plaines, IL).  The  equilibrium dialysis was 
continued until the external radioactivity, recorded as counts per minute (cpm), 
FIGURE  1  SDS  PAGE  illustrates  the  purities  of  lectin  molecules 
used. PAGE was run according to Fairbank et al. (27) under reduced 
conditions (40 mM  DTT).  (a)  DBA,  2  pg; (b)  HPA,  9  pg; (c)  LPA, 2 
pg;  (d)  molecular  weight  standards.  The  size  of  the  DBA  band 
corresponds to that of one subunit;  the two  bands of HPA corre- 
spond  approximately to  1-subunit  and  2-subunits;  and  the  LPA 
band corresponds to 3-subunits. 
reached a  stable reading. The  radioactivity of each lectin solution inside the 
dialysis bag was then determined by the same scintillation counting method. 
The  amount  of  radioactivity  in  the  external  solution  at  equilibrium  was 
compared to that of the  lectin solution inside the dialysis bag at the end of 
equilibrium dialysis for the calculation of the percentage of dialyzable radio- 
activity. 
The Specific Activity of the Lectin Solution:  Theconcentration 
of each radiolabeled lectin solution (in ug N/ml) was determined by multiplying 
the  absorbance  (O.D.)  at  280  nm  by  a  conversion  factor,  which  had  been 
established for each lectin by determining its O.D. at 280 nm and total nitrogen 
with the ninhydrin method and by assuming nitrogen content to be 16% (28). 
The radioactivity of each lectin solution at a known concentration (in cpm/ug) 
was determined by scintillation counting, and the specific activity was calcu- 
lated. 
Cell Count in 2% RBC Suspension:  The cell number per ml of 
the 2% RBC suspension was determined to be 2 x  l0  s RBCs/ml with the use 
of a Coulter Counter (model Za, Coulter Electronics Inc., Hialeah, FL). 
Hemagglutination  Assay:  Twofold  serial  dilutions of  the  lectin 
solution (25  pl  of each) were made in a  96-well microlitrator plate (Cooke 
Engineering Company, Alexander, VA). An equal volume (25/A) of a 2% RBC 
suspension was then added into each well. After l h at 25°C, the settling  patterns 
were read to determine the agglutination titer. The highest dilution of the lectin 
solution showing the detectable agglutination is called the titer. 
Binding of Lectins to  RBCs:  Fresh  normal genotype AO human 
RBCs were washed three times with Tris-buffered saline containing 2.5 mg/ml 
bovine serum albumin, pH 7.4 (TSA). The washed packed cells  were suspended 
in the same buffer solution to give a 2% RBC concentration by volume. Conical 
glass centrifuge tubes (3  ml or 5  ml) were used to carry out the cell binding 
assays. The tubes were acid washed, soaked in 5 mg/m115ovine serum albumin, 
drained, and dried before use. Varying amounts of radiolabeled lectin solution 
were mixed with a fixed number of human RBCs (1  x  10  7) suspended in PBS 
to give a  total volume of 200 ~1. The mixture was kept at 4"C for 21  h with 
constant rotation. The cell suspensions were centrifuged, and aliquots of the 
supernalant were taken for scintillation counting to determine the amount of 
free lectin at the end of the reaction. The pellets were washed twice with PBS, 
dissolved in 300 ~1 of Soluene 350 and 6 ml of toluene-based scintillation fluid, 
and counted to determine the amount of lectins bound to the RBCs. 
Removal  of  N-Acetylneuraminic  Acids  from RBC  Sur- 
faces:  These experiments were performed on  fresh normal human  RBCs 
with genotypes AO and OO.  1 x  107 RBCs were incubated with 250 units of 
neuraminidase (from Vibrio Cholerae, 500 U/ml) (Calbiochem-Behring Corp., 
San  Diego, CA) in 5  ml of TSA at 37"C for  1 h.  After this treatment RBCs 
were washed twice with the TSA solution and prepared as 2% suspensions in 
the same buffer solution. 
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electrophoretic mobility of the normal or neuraminidase-treated RBCs (0. 1% 
suspensions) was determined in a  cylindrical  microelectrophoresis apparatus 
(Grant Instruments [Cambridge] Ltd.,  England) at 25"C (29,  30). The velocity 
of individual cells in the electric field was measured by using a microscope with 
a water-immersion objective.  Twenty such measurements were made in alter- 
nate directions with a polarity switch.  From the velocity  (urn/s) of the cells and 
the voltage gradient (V/cm) of the electrical  field, the electrophoretic mobility 
(um-s-~/V-cm  -t) of the cells was determined. 
RESULTS 
By small volume equilibrium dialysis, the residual dialyzable 
radioactivities of the lectin  solutions radiolabeled with  [3H] 
acetic anhydride were determined to be 0.2, 0.5, and 0.6% of 
their total  radioactivities for HPA, DBA, and LPA, respec- 
tively.  Their specific activities  were 8.5  x  104 cpm/#g (for 
HPA), 8.0 x  104 cpm/#g (for DBA), and 2.9  x  103 cpm/~,g 
(for LPA). Hemagglutination assays showed that titers of the 
three lectins were not changed after radiolabeling. 
These  radiolabeled  lectin  solutions,  unchanged  in  their 
agglutinabilities,  containing minimum dialyzable radioactiv- 
ities and having sufficient specific activities,  were then used 
in the cell binding assays. The binding assays were performed 
to determine the number of lectin molecules bound to each 
RBC and the number of receptor sites on the RBC for each 
of the  lectins.  The  RBCs  used  were  genotype  AO  unless 
otherwise stated. The binding curve for HPA is shown in Fig. 
2 a. When HPA lectin was <0.02 t~M, practically all the added 
molecules were bound to RBCs. With the addition of more 
HPA,  the  slope  of the  binding  curve  changed  to  reach  a 
saturation  level  equivalent  to  3.8  x  105  molecules/RBC. 
Determination of binding at various time periods between  1 
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FIGURE 2  (a) Binding of HPA, DBA, and LPA to human genotype 
AO RBCs. (b) Estimation of DBA receptor sites on human RBCs by 
Steck-Wallach plot. (c) Estimation of LPA receptor sites on human 
RBCs. 
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and 24 h indicated that equilibrium was already reached by 1 
h. 
Fig. 2 a  also shows the binding curve for DBA. With in- 
creasing amounts of DBA, there was a progressive increase in 
binding to RBCs, but saturation was not reached even with 
2.6 #M of the lectin. To estimate the maximum amount of 
DBA  that  can  be  bound  to  the  RBCs,  a  reciprocal  plot 
according to Steck and Wallach (31) was used (Fig. 2b). The 
reciprocal of lectin bound was plotted against the reciprocal 
of free lectin at the end of reaction. The maximum number 
of bound DBA was thus estimated to be 2.7 ×  l0  s molecules/ 
RBC. 
A similar binding assay was carried out for 3H-labeled LPA 
in the presence of 25 mM [Ca  +2] (Fig. 2a). This lectin reacts 
with N-acetylneuraminic acid (32), the sugar residue located 
mainly at the terminal nonreducing end of the carbohydrate 
moieties on RBC membrane surfaces. The maximum binding 
of LPA was estimated, with a reciprocal plot (Fig.  2 c), to be 
1.5 x  106 molecules/RBC. 
The  comparison  of the  binding  curves  of these  lectins 
showed that,  for a  given number of molecules added, there 
were more molecules of HPA bound to the RBC than DBA, 
even though these two lectins have a comparable number of 
receptor sites per RBC (3.8 x  105 for HPA and 2.7 x  105 for 
DBA). The difference was more dramatic at the lower ends 
of  the curves. The saturation level was reached by the addition 
of much less HPA (<0.46 uM) than DBA (>2.6 #M required). 
The number of receptor sites for LPA on genotype AO human 
RBCs was  five times  as  much  as  those  for the  other two 
lectins, and the binding of LPA on RBC exceeds that of the 
other two  lectins  for a  given  number  of molecules  added. 
From the numbers of receptor sites  for each lectin and the 
surface area of human RBCs (---150 #m2), the receptor density 
for each of the lectins on RBC surface can be estimated  as 
2.5 x  103 receptors/~m 2, 1.8 x  10  3 receptors/#m 2, and  10 x 
103 receptors/urn 2 for HPA, DBA, and LPA, respectively. 
To test the influence of the binding of one type of lectin on 
the binding of another, combinations of lectins sharing sugar 
specificities were added together to a known number of RBCs. 
l  x  l0  7 RBCs were treated with a fixed amount of 3H-labeled 
DBA  and  varying amounts  of unlabeled  HPA  in  a  total 
volume of 200 ~l. The results indicate that the binding of 3H- 
labeled DBA was inhibited by HPA (Fig. 3). When 2.6/~M of 
3H-labeled DBA alone was added to 1 x  10  7 RBC, 2.4 x  l05 
molecules of 3H-labeled DBA were bound to each RBC; this 
number was reduced to one-half when HPA was also added 
such that 2.3 x  l0  s HPA molecules were also bound to each 
RBC.  These  findings indicate  the  existence  of overlapping 
receptor sites for these two lectins.  DBA, however, did not 
cause inhibition  of the binding of HPA to RBCs even with 
ratios of DBA to HPA greater than 100:l. RCA1, a galactose- 
specific lectin isolated from Ricinus communis, caused a weak 
inhibition of the binding of HPA to RBCs. The presence of 
17 #M of RCA l with 0.68 t~M of 3H-labeled HPA in our test 
system resulted in a 35% inhibition of the binding of HPA. 
To test the possible effect ofsteric hindrance on the binding 
of lectins  to  receptors  on  RBC  surfaces,  lectins  with  no 
common sugar specificity were paired  in the binding assay. 
LPA was chosen to pair with HPA or DBA; the rationale was 
that  LPA  molecules,  which  are  relatively  large  (molecular 
weight =  400,000) and bound to N-acetylneuraminic acids at 
nonreducing termini of the sugar moieties at the cell surface, 
might decrease the accessibility of other lectin  molecules to their receptors. However, LPA (up to 0.3 ~M) had no effect 
on the binding of 0.02/~M 3H-labeled HPA to human RBCs 
(Fig.  3),  indicating the absence of steric hindrance  for this 
pair of lectins. 
There was also no evidence of steric hindrance when LPA 
was paired with DBA. In fact, the binding of DBA was found 
to be enhanced by the increasing amounts of LPA added (Fig. 
3).  Since LPA reacts with N-acetylneuraminic acid, a  nega- 
tively charged residue, it is possible that such an interaction 
may reduce the electrical charge density of the microenviron- 
ment in the vicinity of DBA  receptors, thus facilitating the 
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UNLABELED  LECTIN  CONCENTRATION  (.uM) 
Influence of one type of lectin (unlabeled) on the bind- 
ing of another type  of  lectin  (labeled,  marked  with  *)  to  human 
RBCs.  Numbers in the parentheses indicate the amount of radiola- 
beled lectins used in each binding experiment. 
binding of the negatively charged DBA molecules (pI =  4.5) 
as a result of a decreased electrostatic repulsion. 
To  study  the  effects of modification  of the  membrane 
surface on the binding of HPA and DBA, human RBCs were 
treated  with  neuraminidase,  which  caused  the  removal of 
~80%  of N-acetylneuraminic acid from genotype AO RBC 
surfaces, as determined by the 3H-labeled LPA binding study 
(data not shown). The neuraminidase treatment resulted in a 
threefold increase in the maximum amount of HPA bound, 
from ~3.8  x  105  to  11.4  x  105/RBC.  Neuraminidase also 
converted OO ceils,  which had no significant HPA binding 
prior to treatment,  to  have HPA  binding  capacity with  a 
maximum of 7.6  x  105 molecules/RBC (Fig.  4).  Therefore, 
neuraminidase treatment exposed additional sites to allow an 
additional 7.6  x  l05 molecules of HPA to bind to 10  7 RBCs 
for both AO and OO cells.  These results indicate that,  for 
both  cell  types,  7.6  x  105  HPA  receptor sites were  newly 
generated after neuraminidase treatment. 
Neuraminidase treatment also caused an enhancement of 
DBA binding to AO cells (Fig.  5 a). From the Steck-Wallach 
reciprocal plot, the affinity of binding was found to be in- 
creased  after neuraminidase  treatment,  but  the  maximum 
number of binding sites per RBC remained unchanged (Fig. 
5 b), indicating that no new sites were generated in AO cells. 
In OO cells, no significant binding was found either before or 
after neuraminidase treatment, and hence there was also no 
generation of binding sites. The increased affinity of DBA for 
its receptors on AO cells after neuraminidase treatment may 
be attributed to the reduction in negative charge density after 
the removal of N-acetylneuraminic acids. The negative charge 
density of the RBC surface can be determined from the cell 
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FIGURE  4  Effect of neuraminidase treatment (N-treated) on the binding of HPA to human RBCs. 
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FIGURE  5  (a)  Binding  curves  of  DBA  on  genotype AO  and  OO 
cells before (~.) and after (O) neuraminidase treatment. (b) Estima- 
tion of DBA receptor sites on genotype AO  human RBCS,  before 
(4,)  and  after  (O)  neuraminidase  treatment.  The  two  lines  with 
different slopes coincide at the intercept,  indicating no alteration 
in the number of receptor sites after N-treatment. 
TABLE  J.  The Agglutinabilities  of AO and OO Cells by HPA and 
DBA before and after Neuraminidase Treatment 
•  TiLer* of the lectin 
Before  After 
Lectin  Concentration  Cell  treatment  treatment 
#M 
H PA  14  AO  8,192  32,768 
OO  0  4,096 
DBA  7.2  AO  64  512 
OO  0  0 
* See Materials and Methods (Hemagglutination  Assay). 
normal RBC had an electrophoretic mobility of 1.19 ~m-s-~/ 
V-cm  -~, the neuraminidase-treated  RBCs did not move sig- 
nificantly in the electrical field. Molecules of DBA, negatively 
charged at pH 7.4, would bind more readily to their receptors 
on the charge-depleted RBC because of a decrease of electro- 
static repulsion. 
The results of lectin binding assays can be used to explain 
the hemagglutination findings (Table I): Genotype AO cells 
treated  with  neuraminidase  became  more  agglutinable  by 
both HPA and DBA; the titer (the highest dilution of lectin 
solution  showing the detectable  agglutination)  increased by 
factors of 4 and 8, respectively. The increase in hemagglutin- 
ation  in  both  cases is  attributable  to the  number of lectin 
molecules bound, either by increasing the number of receptor 
sites  (HPA) or by increasing the affinity of binding (DBA). 
Genotype OO ceils,  normally not agglutinable by HPA even 
at an undiluted concentration of 14 ~M, became agglutinable 
by this lectin, even when the lectin was diluted to 3  x  10  -3 
uM, after neuraminidase treatment,  as 7.6 x  10  5 HPA sites/ 
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RBC were generated. Genotype OO cells after neuraminidase 
treatment  remained  unagglutinable  by  DBA,  even  at  the 
original  undiluted  concentration  of 7.2  uM,  as  no  DBA 
receptor sites were generated. 
DISCUSSION 
The  interactions  of two  OalNAc-reactive  lectins,  isolated 
from Dolichos biflorus and Helix pomatia, with human gen- 
otype AO RBCs have been studied. With the use of tritiated 
lectins, the number of lectin molecules bound to each RBC 
was determined as a function of the amount of lectin added. 
The  number and density of receptor sites  on human  RBC 
surface  for each of the lectins  was derived either  from the 
saturation level of the binding curve or from a reciprocal plot 
analysis. The number of receptor sites for HPA on RBCs of 
genotype AO obtained  in this  study using 3H-labeled  HPA 
(3.8  x  105  sites/RBC)  agrees very well  with the number of 
receptor sites  on A,B cells (3  x  105 to 5  x  l05  sites/RBC); 
these sugar residues determined by Hammerstrom (18) using 
~25I-labeled HPA. The present finding that genotype AO RBCs 
have 2.7 x  l05 sites/RBC for DBA is not far from the value 
of 5.8  x  105 sites/RBC reported by Carter and Sharon (33) 
on group A  RBC (genotype not specified) using '4C-labeled 
DBA and is almost identical to the 2.6 x  l05 sites/cell reported 
by Roland  and  Bourrillon  (34)  for the  chick  embryo cell. 
With the use of ~25I anti-A antibody, Economidou et al. (35) 
found 4.6 x  105 to 8.5 x  l0  S blood group A-specific sites per 
A~B cell, which is comparable to the numbers of receptor sites 
for HPA and DBA. It is noted that these numbers are very 
close  to  the  copy  number  of the  major  RBC  membrane 
glycoprotein, glycophorin (4 x  l05 copies) (36).  Glycophorin 
molecules, however, are unlikely to be the glycoproteins that 
react with  HPA and  DBA, because there  is indication  (33) 
that the glycoprotein receptor for DBA is distinct from the 
peanut  agglutinin  receptor  which  is  similar  to  asialoglyco- 
phorin. Besides, each glycophorin contains 16 oligosaccharide 
chains  with  a  total  of ~30  terminal  sugar  residues  of N- 
acetylneuraminic  acid  with  galactose  and  GalNAc  in  the 
middle of the chain which may not be available for HPA and 
DBA to react with (37, 38). 
That  HPA can inhibit  the binding of DBA suggests that 
these two lectins share some common receptor sites on human 
genotype AO cells.  Both lectins can precipitate blood group 
A  substance,  specifically agglutinate  blood group A  RBCs, 
and react with a-o-GalNAc-(1---~3) o-GalNAc, and o-GalNAc 
(12,  14,  15, 28); these findings further support the suggestion 
that they share common receptors. However, DBA was found 
not to inhibit the binding of HPA on RBCs even at DBA'HPA 
ratios higher than  100:1; this suggests that HPA may have a 
much higher binding affinity for the primary receptors than 
DBA  and  that  HPA  may  be  able  to  bind  to  other  sugar 
receptors which have little or no affinity for DBA. It has been 
shown that HPA also reacts weakly with GlcNAc and  very 
weakly with galactose, whereas DBA does not react with either 
(16,  19, 24). This broader specificity for HPA, together with 
the finding that RCA l, a galactose-specific lectin, can inhibit 
weakly the binding of HPA to RBCs, supports the notion that 
the receptors on RBCs for HPA and DBA are not identical. 
The binding of DBA to genotype AO RBCs is enhanced by 
the removal of N-acetylneuraminic acids from the cell surface 
and  the  interaction  of N-acetylneuraminic  acid  with  LPA. 
These  findings suggest that the interaction  of DBA and  its receptor is sensitive to the neighboring electric  field at the cell 
surface.  Since both N-acetylneuraminic acid and DBA (pI = 
4.5)  are  negatively  charged,  and  since  the  removal  of N- 
acetylneuraminic acid does not change the number of receptor 
sites  for DBA (a finding which confirms a report  by Carter 
and Sharon [33]), it is most likely that a reduction in surface 
electrostatic  repulsive  potential  leads to the  increase  in  the 
affinity  between DBA and its RBC receptor after neuramini- 
dase treatment. 
Neuraminidase treatment generated  new receptor sites (7.6 
x  l05 sites/RBC) on both AO and OO cells for HPA but not 
for DBA. The newly exposed sugar residues  are most likely 
to be galactose,  based  on the  reason that  HPA  reacts  with 
galactose (in addition to GalNAc), whereas DBA does not. In 
addition,  it  has been  shown that  neuraminidase  treatment 
leads to the generation of new receptor  sites (1.8 x  106 sites/ 
RBC)  for  peanut  agglutinin,  which  is  a  galactose-binding 
lectin, on RBCs of both A and B types (33). Thus, the galactose 
residues  exposed after the removal of the terminal N-acetyl- 
neuraminic acid by neuraminidase treatment  may serve as 
new receptors for lectins that react with galactose. 
The experiments presented  here indicate  that  removal of 
the N-acetylneuraminic acid residues  on RBCs with  neura- 
minidase may reduce  surface charge density and expose new 
sugar residues  and that the relative  importance of these two 
mechanisms  in  influencing  lectin  binding  varies  with  the 
lectin.  The mechanisms discussed may also be used to explain 
the different  behaviors in hemagglutination after neuramini- 
dase treatment  of RBCs bearing  different  genetically deter- 
mined antigens (AO and OO cells in this study). By generating 
new sites  for HPA,  neuraminidase treatment caused an in- 
crease  in agglutinability  of both AO and OO cells by HPA. 
By reducing  surface charge and electrostatic repulsion,  neur- 
aminidase treatment caused an increase  in agglutinability  by 
DBA only in AO cells, but not in OO cells since no new sites 
were generated. 
The present  study has provided a molecular basis  for un- 
derstanding the interaction of lectins with their receptors  on 
cell surfaces and helps to elucidate  the mechanisms by which 
agglutination  occurs.  Quantitation  of the  lectin  molecules 
bound on  the  cell  surface  provides  useful  information  for 
analyzing the energies involved in lectin-induced aggregation 
(39).  The methodology and the mechanisms described  may 
be applied to studies on other cell systems, including those in 
normal or diseased states and during development and differ- 
entiation, and on problems related to cell surface topography, 
cell-cell recognition, and cell-cell association. 
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